RusBankrot
We know everything about bankruptcy
05/12/2025
Friday
THIS DAY IN HISTORY:
5 December 
1936 The Stalinist Constitution of the USSR was adopted.
1936 the Stalinist constitution of the USSR was adopted.
1484 Pope Innocent VII initiated the "witch hunt".
1456 An earthquake that destroyed Naples occurred - 35 thousand people died.
1456 occurred an earthquake that destroyed Naples - 35 thousand people died.
5 December
1936 The Stalinist Constitution of the USSR was adopted.
1936 the Stalinist constitution of the USSR was adopted.
1484 Pope Innocent VII initiated the "witch hunt".
1456 An earthquake that destroyed Naples occurred - 35 thousand people died.
1456 occurred an earthquake that destroyed Naples - 35 thousand people died.
THE MANUFACTURER OF THE ARTIFICIAL HEART CARMAT DECLARED BANKRUPTCY
The French company Carmat, specializing in the creation of a fully artificial heart for patients with terminal heart failure, announced the suspension of payments and filed for bankruptcy in the Economic Court of Versailles. From June 30, 2025, the movement of its shares will be suspended until the start of trading on the stock exchange.
Founded in 2008, Carmat reported a critical lack of finances: it is necessary to raise at least ˆ3.5 million by the end of June and about ˆ20 million more by the end of the year. Despite attempts to find investors and launch a fundraising campaign, the required financing could not be achieved. Without these resources, the company risks shutting down operations by the end of June.
Last year's financial statements showed an operating loss of 49.2 million euros for Carmat. This confirmed the conclusion: the company needs at least ˆ35 million in the next 12 months, including ˆ8 million by the end of July, ˆ4 million by the end of September, and another ˆ8 million by the end of 2025. In an attempt to get out of the situation, Carmat also launched an online fundraising campaign, which was an unprecedented step for the medical technology company. Nevertheless, the company is confident that the beginning of bankruptcy proceedings can be the starting point for the protection and restructuring of the business.
Despite the financial crisis, Carmat is committed to providing support to patients who have received its Aeson artificial heart, a device for people on the verge of transplantation. At the moment, 122 such "biological" hearts have been implanted in them.
It is worth recalling that the company has already faced serious problems: from the end of 2021 to October 2022, Carmat suspended the implantation of Aeson after two deaths. During this time, the team has refined the device to increase its security.
The judicial start of the procedure does not mean the end of Carmat's activities – the company continues to look for investors, refine the technology and support patients. However, without significant investments, its future remains very uncertain.
Photo: Freepik
Founded in 2008, Carmat reported a critical lack of finances: it is necessary to raise at least ˆ3.5 million by the end of June and about ˆ20 million more by the end of the year. Despite attempts to find investors and launch a fundraising campaign, the required financing could not be achieved. Without these resources, the company risks shutting down operations by the end of June.
Last year's financial statements showed an operating loss of 49.2 million euros for Carmat. This confirmed the conclusion: the company needs at least ˆ35 million in the next 12 months, including ˆ8 million by the end of July, ˆ4 million by the end of September, and another ˆ8 million by the end of 2025. In an attempt to get out of the situation, Carmat also launched an online fundraising campaign, which was an unprecedented step for the medical technology company. Nevertheless, the company is confident that the beginning of bankruptcy proceedings can be the starting point for the protection and restructuring of the business.
Despite the financial crisis, Carmat is committed to providing support to patients who have received its Aeson artificial heart, a device for people on the verge of transplantation. At the moment, 122 such "biological" hearts have been implanted in them.
It is worth recalling that the company has already faced serious problems: from the end of 2021 to October 2022, Carmat suspended the implantation of Aeson after two deaths. During this time, the team has refined the device to increase its security.
The judicial start of the procedure does not mean the end of Carmat's activities – the company continues to look for investors, refine the technology and support patients. However, without significant investments, its future remains very uncertain.
Photo: Freepik
03.07.2025
